- Report
- July 2024
- 202 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 242 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- September 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 139 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 136 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 130 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- December 2024
- 84 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP

Buprenorphine is an analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Buprenorphine is available in both immediate-release and extended-release formulations, and is typically administered orally or sublingually. It is commonly used in combination with other analgesics, such as acetaminophen or ibuprofen, to provide more effective pain relief.
Buprenorphine is a popular choice for treating chronic pain due to its long-lasting effects and low risk of addiction. It is also used to treat opioid addiction, as it has a lower potential for abuse than other opioids. Buprenorphine is available in generic form, as well as under brand names such as Subutex and Suboxone.
Some companies in the buprenorphine market include Reckitt Benckiser, Indivior, Mylan, and Dr. Reddy's Laboratories. Show Less Read more